212 related articles for article (PubMed ID: 19167420)
1. Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and alpha1-adrenergic receptor.
Kakui N; Yokoyama F; Yamauchi M; Kitamura K; Imanishi T; Inoue T; Koyama T
Pharmacol Biochem Behav; 2009 May; 92(3):393-8. PubMed ID: 19167420
[TBL] [Abstract][Full Text] [Related]
2. Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors.
Rogoz Z; Wrobel A; Dlaboga D; Maj J; Dziedzicka-Wasylewska M
J Physiol Pharmacol; 2002 Mar; 53(1):105-16. PubMed ID: 11939713
[TBL] [Abstract][Full Text] [Related]
3. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
[TBL] [Abstract][Full Text] [Related]
4. Mirtazapine exerts an anxiolytic-like effect through activation of the median raphe nucleus-dorsal hippocampal 5-HT pathway in contextual fear conditioning in rats.
An Y; Chen C; Inoue T; Nakagawa S; Kitaichi Y; Wang C; Izumi T; Kusumi I
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():17-23. PubMed ID: 27137833
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytic-like effect of mirtazapine mediates its effect in the median raphe nucleus.
An Y; Inoue T; Kitaichi Y; Izumi T; Nakagawa S; Song N; Chen C; Li X; Koyama T; Kusumi I
Eur J Pharmacol; 2013 Nov; 720(1-3):192-7. PubMed ID: 24436979
[TBL] [Abstract][Full Text] [Related]
6. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan.
de Boer TH; Nefkens F; van Helvoirt A; van Delft AM
J Pharmacol Exp Ther; 1996 May; 277(2):852-60. PubMed ID: 8627567
[TBL] [Abstract][Full Text] [Related]
7. Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation.
Nakayama K; Sakurai T; Katsu H
Brain Res Bull; 2004 Apr; 63(3):237-41. PubMed ID: 15145142
[TBL] [Abstract][Full Text] [Related]
8. Mirtazapine abolishes hyperthermia in an animal model of serotonin syndrome.
Shioda K; Nisijima K; Yoshino T; Kato S
Neurosci Lett; 2010 Oct; 482(3):216-9. PubMed ID: 20655983
[TBL] [Abstract][Full Text] [Related]
9. The pharmacologic profile of mirtazapine.
de Boer T
J Clin Psychiatry; 1996; 57 Suppl 4():19-25. PubMed ID: 8636062
[TBL] [Abstract][Full Text] [Related]
10. Tolerability and safety aspects of mirtazapine.
Nutt DJ
Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S37-41. PubMed ID: 12404669
[TBL] [Abstract][Full Text] [Related]
11. Subchronic lithium treatment increases the anxiolytic-like effect of mirtazapine on the expression of contextual conditioned fear.
An Y; Inoue T; Kitaichi Y; Nakagawa S; Wang C; Chen C; Song N; Kusumi I
Eur J Pharmacol; 2015 Jan; 747():13-7. PubMed ID: 25438255
[TBL] [Abstract][Full Text] [Related]
12. Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions.
Yamamura S; Abe M; Nakagawa M; Ochi S; Ueno S; Okada M
Neuropharmacology; 2011 Mar; 60(4):550-60. PubMed ID: 21195096
[TBL] [Abstract][Full Text] [Related]
13. 5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala.
Li X; Inoue T; Abekawa T; Weng S; Nakagawa S; Izumi T; Koyama T
Eur J Pharmacol; 2006 Feb; 532(1-2):74-80. PubMed ID: 16460727
[TBL] [Abstract][Full Text] [Related]
14. Effects of the 5-HT2A antagonist mirtazapine in rat models of thermoregulation.
Pawlyk AC; Cosmi S; Alfinito PD; Maswood N; Deecher DC
Brain Res; 2006 Dec; 1123(1):135-44. PubMed ID: 17067560
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of mirtazapine in clinically relevant subgroups of depressed patients.
Nutt DJ
Depress Anxiety; 1998; 7 Suppl 1():7-10. PubMed ID: 9597345
[TBL] [Abstract][Full Text] [Related]
16. Involvement of dopamine D1 receptors and alpha1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test.
Hirano S; Miyata S; Onodera K; Kamei J
Eur J Pharmacol; 2007 May; 562(1-2):72-6. PubMed ID: 17328889
[TBL] [Abstract][Full Text] [Related]
17. Effects of cytochrome P450 (CYP) 3A4 inhibitors on the anxiolytic action of tandospirone in rat contextual conditioned fear.
Nishikawa H; Inoue T; Masui T; Izumi T; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):926-31. PubMed ID: 17376576
[TBL] [Abstract][Full Text] [Related]
18. Bidirectional modulation of classical fear conditioning in mice by 5-HT(1A) receptor ligands with contrasting intrinsic activities.
Youn J; Misane I; Eriksson TM; Millan MJ; Ogren SO; Verhage M; Stiedl O
Neuropharmacology; 2009; 57(5-6):567-76. PubMed ID: 19607850
[TBL] [Abstract][Full Text] [Related]
19. 5-HT-1A receptor responsiveness following subchronic administration of buspirone.
Khan A; Haleem DJ
Pak J Pharm Sci; 2006 Oct; 19(4):333-7. PubMed ID: 17105715
[TBL] [Abstract][Full Text] [Related]
20. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
